Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alexion Pharma Canada Corp.

02 2Alexion Pharma Canada, AstraZeneca Rare Disease

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Eculizumab

Brand Name : SOLIRIS

Patent Number : 2189015

Filing Date : 1995-05-01

Strength per Unit : 10 mg / mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2015-05-01

Date Granted : 2010-04-13

blank

02

Alexion Pharma Canada, Astra...

arrow
Pharmaconex
Not Confirmed

Alexion Pharma Canada, AstraZeneca Rare Di...

Country
arrow
Pharmaconex
Not Confirmed

Eculizumab

Brand Name : SOLIRIS

Patent Number : 2645810

Filing Date : 2007-03-15

Strength per Unit : 10 mg / mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2027-03-15

Date Granted : 2018-12-11

blank

03

Alexion Pharma Canada, Astra...

arrow
Pharmaconex
Not Confirmed

Alexion Pharma Canada, AstraZeneca Rare Di...

Country
arrow
Pharmaconex
Not Confirmed

Eculizumab

Brand Name : SOLIRIS

Patent Number : 3022097

Filing Date : 2007-03-15

Strength per Unit : 10 mg / mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2027-03-15

Date Granted : 2020-10-27

blank